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NF-kB is essential for effective transcription of pri-
mate lentiviral genomes and also activates antiviral
host genes. Here, we show that the early protein
Nef of most primate lentiviruses enhances NF-kB
activation. In contrast, the late protein Vpu of HIV-1
and its simian precursors inhibits activation of NF-
kB, even in the presence of Nef. Although this effect
of Vpu did not correlate with its ability to interact
with b-TrCP, it involved the stabilization of IkB and
reduced nuclear translocation of p65. Interestingly,
however, Vpu did not affect casein kinase II-medi-
ated phosphorylation of p65. Lack of Vpu was asso-
ciated with increased NF-kB activation and induction
of interferon and interferon-stimulated genes (ISGs)
in HIV-1-infected T cells. Thus, HIV-1 and its simian
precursors employ Nef to boost NF-kB activation
early during the viral life cycle to initiate proviral tran-
scription, while Vpu is used to downmodulateNF-kB-
dependent expression of ISGs at later stages.INTRODUCTION
NF-kB (nuclear factor kappa-light-chain-enhancer of activated B
cells) is an inducible transcription factor that is ubiquitously
expressed and regulates the expression of numerous genes in-
volved in cell survival, inflammation, and immunity (Ghosh and
Hayden, 2012; Napetschnig and Wu, 2013). NF-kB also regu-
lates the antimicrobial immune response, including the expres-
sion of interferon-stimulated genes (ISGs) that protect against
viral pathogens (Pfeffer, 2011).
Not only is NF-kB a key mediator of antiviral immune re-
sponses, but it is also exploited by viruses for efficient trans-
cription of viral genes (Chan and Greene, 2012). For example,
binding of NF-kB p50/p65 heterodimers to the tandem kB sites586 Cell Reports 10, 586–599, February 3, 2015 ª2015 The Authorsin the HIV-1 long terminal repeats (LTRs) is critical for viral repli-
cation. The p50/p65 dimers initiate HIV-1 transcription by asso-
ciating with p300, thereby increasing the accessibility of the LTR
for the cellular RNA polymerase II (RNAPII) (Williams et al., 2006).
Furthermore, p50/p65 dimers recruit the P-TEFb complex to in-
crease the processivity of RNAPII and to support RNA elongation
(Williams et al., 2007).
The opposing roles of NF-kB on virus transcription and innate
responses make it necessary for HIV-1 and other primate lentivi-
ruses to tightly regulate its activation. For the accessory protein
Nef, enhancing (Herbein et al., 2008; Mangino et al., 2011), inhib-
itory (Bandres and Ratner, 1994; Niederman et al., 1992), and no
(Yoon and Kim, 1999) effects on NF-kB activity have been re-
ported. Nef is abundantly expressed throughout the viral life
cycle and induces changes in protein trafficking, signal transduc-
tion, and gene expression to promote viral replication and im-
mune evasion. Many simian immunodeficiency viruses (SIVs)
use Nef to counteract the restriction factor tetherin that retains
nascent virions at the cell surface (Jia et al., 2009; Sauter et al.,
2009; Zhang et al., 2009). In contrast, pandemic HIV-1 and SIVs
infectingCercopithecusmonkeysutilize theirVpuprotein tocoun-
teract tetherin (Van Damme et al., 2008; Neil et al., 2008; Sauter
et al., 2009). It has also been reported that tetherin acts as an
innate sensor that activates an NF-kB-mediated antiviral immune
response and that this effect is counteracted by the anti-tetherin
activity of Vpu (Cocka and Bates, 2012; Gala˜o et al., 2012,
2014; Tokarev et al., 2013). However, earlier studies suggested
that Vpu suppresses NF-kB activation by preventing the poly-
ubiquitination and degradation of IkB through sequestration of
the adaptor protein b-TrCP (Akari et al., 2001; Bour et al., 2001).
While many studies investigated the effect of HIV-1 on NF-kB
activation, results were often discrepant and mostly obtained
using the T cell line-adapted NL4-3 molecular clone. Thus, it re-
mains unknown howprimary HIV-1 strains and other primate len-
tiviruses modulate NF-kB activity and how they ensure effective
proviral transcription while minimizing the activation of antiviral
responses. To address these questions, we analyzed nef and
vpu alleles representing nearly the entire spectrum of primate
lentiviruses. We focused on these accessory genes because
their products have been implicated in the modulation of NF-kB
activity and cooperate in other functions, such as downmodula-
tion of CD4 (Lindwasser et al., 2007). We show that the vast ma-
jority of Nef proteins increase NF-kB activity, while Vpu proteins
inhibit the activation of NF-kB independently of their anti-tetherin
function by stabilizing IkBandpreventing nuclear translocation of
p65. Notably, Vpu-mediated inhibition of NF-kB activation is
dominant over the stimulatory effect of Nef and associated with
decreased expression of ISGs. Thus, Nef appears to increase
NF-kB activity early during the viral life cycle (i.e., from viral entry
to expression of Tat, Rev, and Nef from completely spliced viral
RNAs) to initiate proviral transcription, whereas Vpu downmodu-
lates NF-kB activity during later stages (i.e., during expression of
Vpu, Vpr, Vif, and structural proteins from singly and unspliced
viral RNAs) to suppress the antiviral immune response.
RESULTS
Primate Lentiviral Nef Proteins Boost IKKb-Mediated
NF-kB Activation
Activation of NF-kB involves ubiquitination and proteasomal
degradation of its inhibitor IkB (Figure 1A). In the absence of
IkB, NF-kB is translocated into the nucleus, where it binds to
the promoter regions of its target genes. To analyze NF-kB acti-
vation, we took advantage of a reporter vector expressing firefly
luciferase under the control of three NF-kB binding sites and
determined DNA binding and nuclear translocation of p65 by
electrophoretic mobility shift assay (EMSA) and fluorescence
microscopy. Furthermore, we monitored the expression levels
of IkB and activating phosphorylation of p65 at serine 529 by
flow cytometric analyses (Figure 1A).
To determine the effect of primate lentiviral Nef proteins on
NF-kB activity, we analyzed 39 HIV and SIV nef alleles represent-
ing all four groups of HIV-1 (M, N, O, and P), their direct precur-
sors SIVcpz from chimpanzees and SIVgor from gorillas, as well
as a variety of additional SIVs, including the vpu-containing
SIVgsn, SIVmus, and SIVmon strains. To determine the impact
of Nef on NF-kB activation, we cotransfected 293T cells with
vectors coexpressing Nef and enhanced GFP (EGFP) together
with the NF-kB-dependent firefly luciferase reporter construct
and a constitutively active mutant of IKKb. Coexpression of
most Nef proteins from SIVcpz, SIVgor, and HIV-1 enhanced
IKKb-mediated NF-kB activation 2- to 4-fold. Similarly, HIV-2,
SIVsmm, SIVolc, and SIVden Nefs boosted NF-kB activity (Fig-
ure 1B). In contrast, SIVgsn/mus/mon, SIVagm, and SIVrcm
nef alleles did not promote NF-kB activation (Figure 1B). To iden-
tify possible reasons for these differences in Nef function, we
also examined the effect of the Vpr protein on NF-kB activity.
In agreement with published data (Ayyavoo et al., 1997), HIV-1
and SIVcpz Vprs inhibited NF-kB, but the opposite was observed
for SIVgsn/mus/mon Vprs (Figure 1C). Thus, some primate lenti-
viruses may utilize Vpr instead of Nef to boost NF-kB activation,
although it will be important to confirm these effects in cells from
the respective host species.
Since Vpu has been shown to affect NF-kB activation (Akari
et al., 2001; Bour et al., 2001; Gala˜o et al., 2012), we next exam-
ined whether the presence of a vpu gene, which is specific toCHIV-1 and its simian precursors (Schindler et al., 2006), is asso-
ciated with differences in the ability of Nef to modulate NF-kB
activation. We found that nef alleles derived from primate lentivi-
ruses encoding vpuwere not significantly more active (287.3% ±
32.2%, n = 26) than those lacking this accessory gene (226.1% ±
30.9%, n = 13) (Figure 1B).
Overexpression of human tetherin activates the canonical NF-
kB pathway (Cocka and Bates, 2012; Gala˜o et al., 2012; Tokarev
et al., 2013). To determine whether Nef modulates tetherin-
induced NF-kB activation, we cotransfected 293T cells with
the NF-kB dependent firefly luciferase reporter construct,
expression vectors for human tetherin, and various nef alleles.
In general, the effects of Nef on tetherin-dependent NF-kB acti-
vation were modest and did not differ significantly between vi-
ruses encoding vpu or not (Figures 1D). In contrast, HIV-1 and
SIVcpz Nefs clearly enhanced TNFa and p65-induced NF-kB
activation (Figures S1A and 2A). Notably, Nef did not affect
NF-kB activity in the absence of other stimuli (Figure S1B), indi-
cating that it modulates responsiveness to stimulation rather
than activating NF-kB directly.
To obtain insights into the mechanisms underlying Nef-medi-
ated modulation of NF-kB activity, we analyzed a subset of five
nef alleles that differed the most in their effect on NF-kB activa-
tion (Figure 2B). EMSA and immunofluorescence microscopy
revealed that Nef does not affect the quantity of nuclear p65
(Figures S1C and S1D). To elucidate the impact on viral tran-
scription, we compared LTR activation in the presence of
Nefs that enhanced (HIV-1 and SIVcpz) or suppressed (SIVmus
and SIVmon) NF-kB activation (Figure 2C, left). We found that
the former enhanced LTR promoter activity 3- to 6-fold,
whereas the latter had only modest effects (Figure 2C, middle).
Similarly, transcription of the HIV-1 provirus was enhanced by
HIV-1 and SIVcpz, but not by SIVmus or SIVmon Nefs (Fig-
ure 2C, right). Increased NF-kB activation correlated with
enhanced LTR promoter activity and proviral transcription (Fig-
ure 2D). To further examine the effect of Nef on proviral tran-
scription, we infected human peripheral blood mononuclear
cells (PBMCs) with HIV-1 IRES EGFP constructs. In these
constructs, EGFP expression is an indicator of proviral tran-
scription, since EGFP is expressed together with Nef from a
biscistronic RNA via the regular LTR promoter and splice sites.
We found that intact HIV-1 and HIV-2 nef genes increased LTR-
dependent EGFP expression 2-fold in infected primary cells
(Figure 2E). Thus, many primate lentiviruses including HIV-1,
HIV-2, and their SIV precursors use Nef to boost viral transcrip-
tion through NF-kB activation.
To determine which domains in Nef are involved in increasing
NF-kB activity, we examined 21 mutants of an HIV-1 nef allele
(NA7) derived directly from an infected patient (Figure S2A)
(Greenberg et al., 1997). All mutant Nefs were efficiently ex-
pressed (Figure S2B). Functional analyses showed that multiple
amino acid residues across the Nef sequence are important for
efficient enhancement of NF-kB activity (Figure S2C). For
example, mutations in the (PxxP)3 region that interacts with
SH3 domain-containing cellular kinases as well as two acidic
C-terminal residues (E154/E155) were critical for Nef-mediated
enhancement of NF-kB activity. Moreover, enhancement of
NF-kB activity was separable from other Nef functions, suchell Reports 10, 586–599, February 3, 2015 ª2015 The Authors 587
Figure 1. Stimulation of NF-kB Activity by Primate Lentiviral Nef Proteins
(A) Schematic of the canonical NF-kB signaling pathway. Inducers used in this study are highlighted by yellow boxes and methods used to monitor the activation
levels of NF-kB in light blue boxes.
(B) Nef boosts IKKb-induced NF-kB activation. 293T cells were cotransfected with the indicated nef alleles, a firefly luciferase reporter construct under the control
of three NF-kB binding sites, a Gaussia luciferase construct for normalization, and expression vectors for a constitutively active mutant of IKKb (ca IKKb) as
inducer of NF-kB. Luciferase activities were determined 40 hr posttransfection. Each data point represents one nef allele from the respective groups of primate
lentiviruses. Mean values of three to six transfections are shown in (B) and (D). In the right panel, nef alleles were grouped based on the presence or absence of a
vpu gene in the respective viruses. HIV-1 group N was excluded from this analysis because their Vpus are poorly active.
(C) Vpr proteins of SIVgsn/mus/mon promote NF-kB activation. 293T cells were transfected and analyzed as described above. Results showmean values (±SEM)
from six transfections.
(D) Effect of Nef on tetherin-inducedNF-kBactivation. 293T cells were transfected as described for (B), using human tetherin as inducer of NF-kB. Each data point
represents one nef allele.
See also Figure S1.as downmodulation of CD4 and MHC-I and stimulation of HIV-1
replication in PBMC cultures, which also contribute to efficient
replication in human PBMCs (Kirchhoff et al., 2008). However,
we found a significant correlation (R2 = 0.3208; p = 0.0054) be-
tween Nef-mediated enhancement of NF-kB activity and virion
infectivity, suggesting that both aremediated by overlapping do-
mains. For example, changes of R71A, D86A, and E154A/E155A
disrupted these two activities but had little if any effect on other
Nef functions (Figure S2C).588 Cell Reports 10, 586–599, February 3, 2015 ª2015 The AuthorsPrimate Lentiviral Vpus Inhibit NF-kB Activation
Next, we examined the effects of Vpu on NF-kB activity. Initially,
we focused on tetherin-induced NF-kB activation because it has
been shown that HIV-1 groupMVpus suppress this effect (Gala˜o
et al., 2012; Tokarev et al., 2013). To determinewhether suppres-
sion of NF-kB activation by Vpu is conserved among primate len-
tiviruses, we analyzed 33 vpu alleles from essentially all groups
of HIV-1 and SIV encoding this accessory gene. As shown in
the left panel of Figure 3A, most primate lentiviral Vpus inhibited
Figure 2. Primate Lentiviral Nef Proteins Stimulate Viral LTR Activity
(A) Nef-mediated modulation of NF-kB activation by different inducers. 293T cells were transfected with the indicated nef alleles as described for Figure 1B and
activated via TNFa stimulation (25 ng/ml) or cotransfection of tetherin, ca IKKb, or p65. Stars indicate statistically significant differences (*p < 0.05, **p < 0.01,
***p < 0.001). Mean values of three to six transfections (±SEM) are shown in (A)–(C).
(B) 293T cells were transfected with nef alleles differing strongly in their effect on NF-kB activity as described for Figure 1B using ca IKKb as inducer.
(C) 293T cells were cotransfected with Nef expression vectors, ca IKKb, a Gaussia luciferase construct for normalization, and an NF-kB-dependent firefly
luciferase reporter vector (left), an HIV-1 LTR firefly luciferase reporter construct (middle), or a nef and env defective proviral HIV-1 NL4-3 IRES luciferase construct
(right).
(D) Correlations between the levels of NF-kB activity and (upper) LTR-driven or (lower) proviral expression of a luciferase reporter gene.
(E) Levels of EGFP expression in PBMC cultures infected with HIV-1 IRES EGFP constructs expressing the NL4-3 or HIV-2 BEN nef alleles or containing a
disrupted nef gene (nef). Results were obtained from infections of three PBMC donors.
See also Figure S2.tetherin-induced NF-kB activation. The exception were Vpu pro-
teins from HIV-1 group N, which are also poor tetherin antago-
nists (Sauter et al., 2012) (Figure 3A). Nonetheless, the finding
that SIVcpz, SIVgor, and HIV-1 group O Vpus were active in
this assay came as a surprise, since these viruses use Nef
instead of Vpu to antagonize tetherin in their respective hosts
(Sauter et al., 2009; Kluge et al., 2014). Thus, vpu alleles known
to differ in their ability to antagonize tetherin did not differ in their
ability to suppress tetherin-induced NF-kB activation (Figure 3A,
right panel), suggesting that Vpu targets a later step in the NF-kB
signaling pathway. Indeed, we found that most Vpu proteins
blocked IKKb-induced NF-kB activation by >90% (Figure 3B),
which was conserved in all lineages of SIV and HIV-1 (except
group N), including all group M subtypes (Figures 3A–3C). We
also examined the effects of tetherin and IKKb at different doses
and found that Vpu inhibits both of them with similar efficacy
(Figure S3A). While primate lentiviral Nef proteins enhanced IKK-Cb-induced (but not tetherin-induced) NF-kB activation (324.7% ±
34.5%, n = 44; versus 95.1% ± 9.0%, n = 37; mean values ±
SEM), HIV-1 and SIV Vpus suppressed this process (Figure 3D,
left). These differences were particularly striking for Nef and
Vpu proteins from pandemic HIV-1 M strains: the former
increased IKKb-induced NF-kB up to 10-fold (mean 462.7% ±
119.6%, n = 10), and the latter reduced it by up to 50-fold
(mean 11.9% ± 7.1%, n = 7) (Figure 3D, right).
Recruitment of b-TrCP by Vpu Is Not Sufficient
for Inhibition of NF-kB
Our finding that Vpu suppressed IKKb-induced NF-kB activa-
tion suggested that it may target the IKK complex directly or
interfere with a factor downstream in the NF-kB signaling
pathway. The effects of Vpu on NF-kB activation were similar
to those of a transdominant-negative mutant of b-TrCP and
the poxvirus A49 protein, which sequesters b-TrCP (Figure 4A)ell Reports 10, 586–599, February 3, 2015 ª2015 The Authors 589
Figure 3. Inhibition of NF-kB Activation by Vpu
(A and B) 293T cells were transfected with the indicated vpu alleles as described for Figure 1B using (A) human tetherin or (B) ca IKKb as inducer. Each data point
represents one vpu allele. Mean values of three to nine transfections are shown in (A)–(C). In the right panels, the data sets were grouped based on the ability of
Vpu to antagonize human tetherin. HIV-1 N Vpus cannot be clearly assigned to the active or defective group and are thus not shown.
(C) Inhibition of NF-kBactivation by Vpus of different subtypes of HIV-1 groupM. 293T cells were transfectedwith vpu alleles from the indicated HIV-1M subtypes
as described for Figure 1B using ca IKKb as inducer.
(D) Comparison of Nef- and Vpu-mediated modulation of ca IKKb- and tetherin-induced NF-kB activation.
See also Figure S3.(Mansur et al., 2013). It has been suggested that NL4-3 Vpu
inhibits the degradation of IkB by acting as a transdominant
inhibitor of b-TrCP (Bour et al., 2001). This effect was pro-
posed to be dependent on a DSGxxS motif in Vpu that is
phosphorylated at the serine residues by casein kinase II
(CKII) and interacts with b-TrCP to recruit the E3 ubiquitin-
ligase SCF (Skp1, Cullin, F-box) complex (Douglas et al.,
2009; Mangeat et al., 2009; Margottin et al., 1998). Thus, it
was unexpected that mutation of these serine residues to
alanine in two HIV-1 (CH106) and SIVcpz (EK505) Vpus
reduced, but not fully disrupted, their ability to suppress NF-
kB activation (Figures 4B and S3B). Consistent with this, the
mutant Vpus maintained some activity in reducing the binding
of p65/p50 dimers to DNA (Figure 4C). Of note, the Vpu of the
T cell line-adapted NL4-3 clone, which has been utilized in
most previous studies, was substantially less active in
reducing IKKb-induced NF-kB activation (62.0% ± 9.5%)
than the Vpu proteins of 28 other HIV-1 M strains analyzed
(5.3% ± 1.3%; p < 0.0001).
To examinewhether the capability of various Vpus to suppress
NF-kB activation correlated with their ability to interact with590 Cell Reports 10, 586–599, February 3, 2015 ª2015 The Authorsb-TrCP, we fused the N-terminal fragment of a click beetle
luciferase to the C terminus of various Vpus and the C-terminal
fragment of this luciferase to theN terminus of b-TrCP (Figure 4D,
upper). We found that both wild-type HIV-1 (CH106) and SIVcpz
(EK505) Vpus that block NF-kB activation as well as a group N
(YBF30) Vpu that increases its activation interacted efficiently
with b-TrCP (Figure 4D, lower). As expected (Sauter et al.,
2012), mutation of the serine phosphorylation sites impaired
the interaction of Vpu with b-TrCP. However, the effects of
various Vpu proteins onNF-kB activity did not correlate with their
b-TrCP binding capacity. Furthermore, Vpu stabilized IkBa upon
stimulation with TNFa (Figures 4E and S4A). This effect was
partially abrogated by serine to alanine mutations in the DSGxxS
b-TrCP binding motif. Since p65 and Vpu are both phosphory-
lated by CKII (Schubert et al., 1992), we also examined whether
phosphorylation of p65 at Ser529, a known target of CKII (Wang
et al., 2000), is inhibited by Vpu, but we found that this was not
the case (Figures 4F and S4B). Thus, Vpu stabilizes IkB in a
b-TrCP-dependent manner but also inhibits NF-kB activation
by mechanisms that are independent of b-TrCP and CKII
sequestration.
Figure 4. Mechanism of Vpu-Mediated Inhibition of NF-kB Activation
(A) 293T cells were cotransfected with luciferase constructs as described for Figure 1B and expression vectors for the indicated vpu alleles, poxvirus protein A49,
or a dominant-negative mutant of b-TrCP1. TNFa stimulation (25 ng/ml), overexpression of tetherin, ca IKKb, or p65were used to activate NF-kB. (A) and (B) show
mean values (±SEM) derived from three to nine transfections.
(B) Effect of mutations in the DSGxxS b-TrCP interaction site of various Vpus on IKKb-induced NF-kB stimulation. 293T cells were transfected with the indicated
vpu alleles as described for Figure 1B, using ca IKKb as inducer.
(legend continued on next page)
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Vpu Inhibits Nuclear Translocation of p65
To define the determinants within Vpu that are involved in NF-
kB inhibition, we performed triple-alanine scan mutagenesis in
the cytoplasmic domains of two HIV-1 (WITO, CH106) Vpus.
Western blot analyses showed that all mutant Vpus were effi-
ciently expressed (Figure S4C). Whereas mutations in the
DSGxxS b-TrCP binding motif abolished the ability of WITO
Vpu to block NF-kB activation, the effects of these mutations
were less pronounced in CH106 Vpu (Figure S4D). In addition
to mutations of the serine residues that are phosphorylated
and critical for b-TrCP binding, some alanine mutations in the
first a-helix of Vpu (i.e., RAE49-51AAA) impaired inhibition of
NF-kB activation. This is in agreement with recent findings
showing that mutations of not only the b-TrCP binding site but
also adjacent residues R45, R49, E51, G59, and E62 are re-
quired for efficient Vpu-mediated inhibition of tetherin signaling
(Pickering et al., 2014). Thus, this region in Vpu appears to affect
NF-kB activity by both b-TrCP-dependent and independent
mechanisms.
We next analyzed whether subcellular localization is important
for the ability of Vpu to suppress NF-kB activation. To address
this, we fused the NL4-3, CH106, and EK505 Vpus to a signal
(KKDQ) previously shown to retain Vpu in the endoplasmic re-
ticulum (ER) (Skasko et al., 2011). This completely disrupted
the modest anti-NF-kB activity of NL4-3 Vpu (Figure S4E). In
comparison, the CH106 and EK505 KKDQ-Vpus still inhibited
NF-kB activation, albeit with an 4-fold lower potency than the
parental forms. Thus, transport of Vpu to a post-ER compart-
ment is required for full anti-NF-kB activity.
Finally, we microscopically analyzed the subcellular localiza-
tion of p65 in the presence of wild-type (WT) and mutant Vpus
before and after activation with TNFa. These analyses showed
that WT HIV-1 (NL4-3, EK505, and CH106) Vpu proteins effi-
ciently inhibited nuclear translocation of p65 (Figures 5 and
S5). The SS/AA mutations in the DSGxxS motif of these Vpus
largely abolished this activity. Thus, Vpu is a potent inhibitor of
nuclear translocation of p65.
Vpu Suppresses NF-kB-Dependent Immune Activation
in a Dominant Manner
Our results suggested that Nef increases NF-kB activity early
during the viral life cycle, whereas Vpu suppresses it during the
late stage. Since Nef is expressed throughout the viral life cycle,
we reasoned that the effect of Vpumust be dominant. Consistent
with this, Vpu prevented IKKb-induced NF-kB activation even in
the presence of Nef (Figure 6A). To examine the effects of Nef(C) Vpu reduces p65-DNA association. 293T cells were transfected with the in
performed 24 hr posttransfection. The 50-labeled oligonucleotide probes correspo
nuclear extracts. Numbers provide the mean intensities of the p65/p50 signals n
(D) Interaction of Vpu with b-TrCP. 293T cells were transfected with equal amount
of click beetle green and Vpu C-terminally fused to the N-terminal fragment of cl
living cells by addition of D-luciferin and quantification of bioluminescence. The
(E) Vpu stabilizes IkBa. 293T cells were transfected with plasmids expressing the
Cells were stimulated 24 hr posttransfection with TNFa (10 ng/ml) or left un
permeabilized and levels of IkBa were analyzed by flow cytometry. Stars indica
(*p < 0.05; **p < 0.01).
(F) Vpu does not affect phosphorylation of p65 at Ser529. Levels of phosphorylate
See also Figure S4.
592 Cell Reports 10, 586–599, February 3, 2015 ª2015 The Authorsand Vpu on NF-kB activity in HIV-1-infected cells, we generated
a derivative of the SupT1 T cell line stably expressing a short-
lived version of the firefly luciferase under the control of an
NF-kB-dependent promoter. This cell line, named SupD1, was
infected with VSV-G pseudotyped HIV-1 M molecular clones
as well as vpu-defective mutants thereof, and the levels of NF-
kB-dependent luciferase activity were measured at different
times posttransduction. We found that Nef was expressed prior
to Vpu (Figure 6B) and that defective vpu genes were associated
with substantially higher levels of NF-kB activation (Figure 6C).
While the decline of NF-kB activity at later time points was likely
due to virus-induced cytopathic effects, the observed differ-
ences in NF-kB activation were not due to different replication
rates (Figure S6A). Finally, analysis of the subcellular localization
of p65 in cells transduced with WT and vpu-defective HIV-1
(CH167 and CH293) infectious molecular clones before and after
activation with TNFa showed that Vpu blocks translocation of
p65 from the cytoplasm to the nucleus in HIV-1-infected cells
(Figure 6D).
To examine whether Vpu affects the expression of antiviral
genes viamodulation of NF-kB, we analyzed the effect of various
Vpus on the transcriptional activity of the IFNb promoter upon
stimulation with Sendai virus. Vpu proteins from both primary
HIV-1 group M (WITO, CH106) and SIVcpz (EK505) strains
reduced IFNb promoter activity by95% (Figure 7A). In contrast,
NL4-3 and group N (YBF30) Vpus achieved only 70% and 33%
inhibition, respectively. Most importantly, mutations in the two-
serine phosphorylation sites in the DSGxxS b-TrCP interaction
motif did not reduce the ability of HIV-1 (NL4-3, CH106) and
SIVcpz (EK505) Vpu proteins to suppress IFNb promoter activity.
The effects of these Vpu proteins on NF-kB activation and IFNb
promoter-dependent gene expression correlated significantly
(R2 = 0.89; p = 0.0001).
It is controversial whether Vpu inhibits innate immune activa-
tion by degradation of IRF-3 (Doehle et al., 2012) and/or inhi-
bition of NF-kB (Hotter et al., 2013). To further examine this,
we mutated the single NF-kB site in the IFNb promoter (Fig-
ure 7B, upper panel). As expected, this mutation abolished
responsiveness of the IFNb promoter to NF-kB activation via
IKKb (Figure 7B, left panel) and reduced induction by Sendai
virus (Figure 7B, middle and right panel). However, the
mutated promoter was not inhibited by Vpu (Figure 7B, right
panel). These results show that Sendai virus induces IFNb pro-
moter activity in 293T cells through both NF-kB and IRF-3 and
confirmed that Vpu suppresses activation through inhibition of
NF-kB and not IRF-3.dicated expression vectors. Nuclear extracts were prepared and EMSA was
nding to the HIV-1 NF-kB sites or to an Oct-1 consensus were incubated with
ormalized to Oct1 of two independent experiments.
s of plasmids expressing b-TrCP N-terminally fused to the C-terminal fragment
ick beetle green. After 40 hr, click beetle luciferase activity was determined in
mean values of three transfections ±SEM are shown.
indicated vpu alleles or a dominant-negative mutant of IKKb (dom. neg. IKKb).
treated. Fifteen minutes after stimulation, cells were harvested, fixed, and
te a statistically significant stabilization of IkB compared to the vector control
d p65 (Ser529) were determined by flow cytometry as described for Figure 4E.
Figure 5. Vpu Inhibits Nuclear Translocation of p65
HeLa cells were transfected with plasmids expressing EGFP alone (vector) or also the indicated Vpu proteins. Cells were treated or not with TNFa for 15 min and
analyzed by microscopy 24 hr after transfection. Subcellular localization of endogenous p65 was monitored by indirect immunofluorescence. Cells transfected
with the Vpu expression or control constructs were identified by detection of EGFP expression. Nuclei of transfected cells are indicated by white arrows in the
close-up images on the right. The lower panel shows the quantity of nuclear and cytoplasmic p65 in cells expressing no (), medium (+), or high (++) levels of
EGFP (and hence Vpu). All samples were blinded, to avoid an experimenter-caused bias in the results. Scale bars indicate 10 mm. The results were derived from
the analysis of 213–416 individual cells.
See also Figure S5.Wealsoquantified the release of 80 cytokines fromSupD1cells
infectedwithWTand vpu-defectiveHIV-1 (CH167). A quantitative
protein array of the supernatants (Figure S6B) revealed that pro-
ductionof four genes (eotaxin 1, insulin-like growth factor-binding
proteins IGFBP1 and IGFBP2, as well as hepatocyte growth fac-
tor [HGF]) was markedly increased in cells infected with the vpu-
deficient virus (Figures 7C and S6C). Notably, these four genes
are known to be induced by NF-kB (Pahl, 1999). Furthermore,
HGF and eotaxin 1 are both ISGs, and high plasma levels of the
latter are associated with reduced susceptibility to infection in
the SIV/macaque model (Promadej-Lanier et al., 2010). Interest-
ingly, it has been reported that a single-nucleotide polymorphism
in the eotaxin 1 promoter affects susceptibility to HIV-1 infectionC(Modi et al., 2003). In contrast, none of 48 genes known not to
be regulated by NF-kB were affected by the absence of Vpu.
Finally, we analyzed the expression of ICAM-1 and MHC-I on
infected primary cells. Both proteins are key players of inflam-
matory immune responses and established targets of NF-kB
(Baumann et al., 2007; Girdlestone et al., 1993). The surface
levels of ICAM-1 and MHC-I increased by 35% to 73% on
PBMCs and human lymphoid aggregate cells (HLAC) infected
with vpu-deficient HIV-1 compared to cells infected with the
wild-type virus (Figures 7D and S6D). Next, we infected PBMCs
with wild-type or vpu-defective HIV-1 CH167 and CH198 con-
structs and determined the effect of Vpu on the transcriptional
levels of IFNb and several NF-kB- and IFN-dependent genes.ell Reports 10, 586–599, February 3, 2015 ª2015 The Authors 593
Figure 6. Vpu Suppresses NF-kB Activation in HIV-1-Infected Cells in a Dominant Manner
(A) 293T cells were transfected with the indicated HIV-1M JR-CSF nef and/or vpu alleles as described for Figure 1B.Mean values of three transfections ±SEM are
shown.
(B and C) SupD1 cells stably expressing a short-lived version of the firefly luciferase under the control of an NF-kB-dependent promoter were infected with (B)
HIV-1 CH167 or (C) the indicated VSV-G pseudotyped HIV-1 strains. Cells were harvested at the indicated time points posttransduction to determine (B) viral
(legend continued on next page)
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Figure 7. Vpu Suppresses the Induction of IFNb and ISGs
(A) 293T cells were cotransfected with the indicated vpu alleles, a firefly luciferase reporter construct under the control of the IFNb promoter, and a Gaussia
luciferase construct for normalization. Cells were infected with Sendai virus 16 hr posttransfection to activate the IFNb promoter. Luciferase activities were
determined 40 hr posttransfection. The mean values of two independent experiments in triplicates ±SEM are shown.
(B) Top: mutation introduced into the IFNb promoter firefly reporter construct. 293T cells were cotransfected with plasmids expressing theWITO Vpu (or an empty
vector control) together with wild-type or NF-kB unresponsive IFNb promoter firefly and control Gaussia luciferase constructs. Cells were stimulated by infection
with Sendai virus (SeV) 24 hr posttransfection and luciferase assays were performed 16 hr later. Firefly luciferase signals were normalized to the corresponding
Gaussia luciferase signals.
(C) Cytokine release from SupD1 cells infected with the HIV-1 M CH167 construct or a vpu-deficient mutant thereof. Shown are cytokines levels obtained for the
vpu-deficient mutant relative to the wild-type virus (100%), grouped into target and nontarget genes of NF-kB. Cytokines that were markedly induced in the
absence of Vpu are highlighted Eo1, Eotaxin1.
(D) Effect of Vpu on ICAM-1 and MHC-I expression in HIV-1-infected primary cells. PBMCs or HLACs were transduced with HIV-1 M CH167 wild-type or a vpu-
deficient mutant thereof. Three days postinfection, ICAM-1 and MHC-I surface levels were analyzed by flow cytometry. The mean values of three to five in-
dependent experiments ±SEM are shown.
(E and F) PBMCs from six different donors were transduced with wild-type or vpu-defective HIV-1 CH167 and CH198 constructs. Cells were harvested 72 hr
posttransduction. Total cellular RNA was isolated and reversely transcribed, and mRNA expression levels of (E) IFNb or (F) the indicated NF-kB target genes and
ISGs were measured by quantitative real-time PCR. (E)–(G) show mean values of 12 transductions ±SEM.
(G) The percentage of HIV-1-infected PBMCs used in (E) and (F) was determined by flow cytometry after intracellular p24 staining.On average, lack of Vpu was associated with 100-fold
increased induction of IFNb and 3- to 5-fold increased expres-
sion of ICAM-1, HLA-B, IFI44L, and tetherin (Figures 7E and 7F).
These alterations were observed in bulk mRNA preparationsprotein expression or (C) the activation levels of NF-kB. The graph in (B) shows the
32 hr posttransduction (100%).
(D) HeLa cells were transduced with wild-type or vpu-defective HIV-1 CH167 and
infected cells were identified by staining with a Nef-specific antibody. Nuclei of tra
The lower panel shows the quantity of nuclear and cytoplasmic p65 in cells expres
were blinded to avoid an experimenter-caused bias in the results. Scale bars ind
cells.
See also Figure S6.
Cand only 4% of the cells were infected by HIV-1 (Figure 7G).
Thus, the results suggest that lack of Vpu is associated with
75- to 125-fold increased expression levels of these ISGs in
HIV-1-infected primary T cells.signal intensities of Vpu, Nef, and Env expression relative to those obtained at
CH293 constructs and analyzed as described in the legend to Figure 5. HIV-1-
nsduced cells are indicated by white arrows in the close-up images on the right.
sing no (), medium (+), or high (++) levels of Nef (and hence HIV-1). All samples
icate 10 mm. The results were derived from the analysis of 354–519 individual
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DISCUSSION
In this study, we show that the great majority of HIV-1 and SIV
Nefs increase NF-kB activity, including in primary PBMCs. It is
well established that Nef is abundantly expressed during the
earliest stages of the viral replication cycle and that NF-kB acti-
vation is essential for effective proviral transcription. Thus, our
results suggest that most primate lentiviral Nef proteins activate
NF-kB to initiate efficient viral transcription. However, NF-kB
also induces the expression of many antiviral host factors. To
suppress this induction, HIV-1 and its SIV precursors employ
Vpu during the later stages of the viral life cycle. The inhibitory ef-
fect of Vpu is dominant over the stimulatory effect of Nef (Fig-
ure 6A), and vpu-defective HIV-1 constructs induce substantially
higher levels of NF-kBactivity (Figure 6C) aswell as IFNb and ISG
expression (Figure 7) in infected T cells than the corresponding
wild-type viruses. Thus, it seems clear that HIV-1 and its SIV pre-
cursors use Nef and Vpu to fine-tune NF-kB activity during the
viral life cycle to achieve both efficient viral replication and im-
mune evasion.
Vpu proteins from the rare HIV-1 group N strains showed
significantly lower activity in suppressing NF-kB activation than
those from pandemic HIV-1 M strains and SIVcpz. This further
supports the hypothesis that HIV-1 N Vpus lost important func-
tions following cross-species transmission, such as the ability
to reduce the surface expression of CD4 (Sauter et al., 2009,
Sauter et al., 2012). Lack of Vpu-mediated inhibition of NF-kB
was associated with increased transcriptional activity of the
IFNb promoter. It will be interesting to determine whether
HIV-1 N strains induce stronger innate immune responses than
pandemic HIV-1 group M strains.
Vpu proteins suppressed tetherin-mediated NF-kB activation
irrespective of their ability to antagonize this protein’s effect on
virus release, suggesting multiple interactions with the signaling
pathway. We found that Vpu-mediated degradation of tetherin
and inhibition of nuclear translocation of p65 both contribute to
the suppression of NF-kB activity. However, the exact mecha-
nism underlying Vpus ability to inhibit NF-kB activation remains
to be established. It has been suggested that Vpu prevents
degradation of IkB by acting as a transdominant-negative inhib-
itor of b-TrCP (Bour et al., 2001). In agreement with this, IkB sta-
bilization and inhibition of p65 nuclear translocation depend on
the presence of an intact b-TrCP binding motif and interaction
of Vpu with b-TrCP was essential for full inhibition. However,
Vpu proteins that failed to recruit b-TrCP were still able to inhibit
binding of p65 to its target sequences and to reduce NF-kB-
dependent gene expression (Figures 4B and 4C). Thus, the inter-
action of Vpu with b-TrCP is neither required nor sufficient for
the inhibition of NF-kB activation. A possible explanation is
that the NL4-3 Vpu used in most studies is a much weaker inhib-
itor of NF-kB activation than vpu alleles derived from primary
HIV-1 strains. Furthermore, the disruptive effect of SS/AA muta-
tions in the DSGxxS b-TrCP interaction motif is more severe in
the NL4-3 Vpu than in most primary HIV-1 Vpus, further empha-
sizing the importance of using primary HIV-1 genes. Notably,
mutations in the DSGxxS site may not only prevent b-TrCP
binding but also alter the structure and function of the C-terminal
Vpu domain (Coadou et al., 2003).596 Cell Reports 10, 586–599, February 3, 2015 ª2015 The AuthorsThe results of the present study add to the evidence that early
HIV-1 gene products, i.e., Nef and Tat, promote NF-kB activa-
tion, whereas late products, such as Vpu, suppress it (Akari
et al., 2001; Bour et al., 2001; Felzien et al., 1998; Fiume et al.,
2012; Herbein et al., 2008; Leulier et al., 2003; Liu et al., 2013;
Mangino et al., 2011; Roux et al., 2000; Varin et al., 2005). How-
ever, we also show that there is a tight interplay between Nef
and Vpu function, strongly suggesting that the opposing effect
of these two viral factors optimize viral transcription in the face
of innate antiviral responses. The importance of timing, along
with the fact that accessory proteins from primary HIV-1 show
functional differences from the lab-adapted NL4-3 strain, thus
provide an explanation for previous seemingly discrepant
results.
Finally, we provide new insight into why Nef proteins of vpu-
containing primate lentiviruses lost their ability to downmodulate
TCR-CD3 from the cell surface. Stimulation via the TCR-CD3 re-
ceptor also induces NF-kB activation and thus expression of im-
mune genes. It seems that most primate lentiviruses prevent this
by Nef-mediated downmodulation of the TCR-CD3 receptor
from the cell surface, whereas HIV-1 and its vpu-containing sim-
ian precursors utilize Vpu to prevent NF-kB activation at a later
step of the signaling pathway. However, Nef proteins that down-
modulate TCR-CD3 boost IKKb-induced NF-kB activation as
efficiently as Nefs lacking this function. Thus, these Nef proteins
uncouple stimulation of NF-kB activation in infected T cells from
the interaction with antigen-presenting cells. It is thus possible
that Nef may stimulate NF-kB more rapidly than it takes to effi-
ciently remove TCR-CD3 from the cell surface.CONCLUSIONS
In summary, our data show that Nef and Vpu exert opposing
effects on NF-kB activity and tightly regulate the activation of
this transcription factor to ensure efficient viral transcription
while minimizing the expression of antiviral genes. Nef does
not enhance NF-kB activation on its own, but it augments the
responsiveness to other stimuli, most likely because a certain
state of cellular activation is needed to allow productive virus
infection.We also show that primate lentiviral Vpu proteins inhibit
NF-kB activation and antiviral gene expression independently of
their anti-tetherin activity. Thus, a tight regulation of NF-kB by
Nef and Vpu seems critical for viral replication, immune evasion,
and pathogenesis.EXPERIMENTAL PROCEDURES
Expression Vectors
Cloning of vpu, nef, and tetherin alleles into the bicistronic cytomegalo-
virus promoter-based pCG expression vector coexpressing the GFP was per-
formed as described previously (Sauter et al., 2009). PCR with primers intro-
ducing XbaI and MluI restriction sites flanking the reading frames was used
to generate mutant or chimeric vpu and nef alleles for cloning into the pCG
vector.
Proviral HIV-1 Constructs
Generation of HIV-1 NL4-3-based proviral constructs and infectious molecular
clones of T/F and CC HIV-1 strains has been described previously (Parrish
et al., 2013; Schindler et al., 2006).
Cell Culture and Transfections
Cells were cultured and transfected as described in Supplemental Experi-
mental Procedures.
NF-kB Activation
Dual luciferase assays with an NF-kB-dependent firefly luciferase and
a Gaussia luciferase construct under the control of a minimal pTAL pro-
moter for normalization were performed to determine the effect of Nef or
Vpu on NF-kB activity as described in Supplemental Experimental
Procedures.
EMSA
Nuclear extracts were prepared, and EMSAs with an HIV-1 NF-kB probe were
performed as previously described (Van Lint et al., 1996). See Supplemental
Experimental Procedures for details.
Viral LTR Activity
To determine whether Nef enhances viral promoter activity via modulation of
NF-kB, 293T cells were cotransfected with expression vectors for nef and a
constitutively active mutant of IKKb, a Gaussia luciferase construct for normal-
ization, and an HIV-1 LTR firefly luciferase reporter construct (LTR_Luc) or an
NL4-3 nef- and env-deficient proviral construct coexpressing firefly luciferase
via an IRES (HIV-1_IRES_Luc). Luciferase activities were determined 40 hr
posttransfection.
Microscopic Analyses of p65
Subcellular localization of p65 in the presence of Nef or Vpu was monitored by
indirect immunofluorescence as outlined in Supplemental Experimental
Procedures.
Click Beetle Luciferase Assay
Generation of Vpu constructs fused to fragments of click beetle luciferase
and a protocol of this assay have been described previously (Sauter et al.,
2012).
NF-kB Activity in HIV-1-Infected Cells
The effect of HIV infection on NF-kB activity was determined as outlined in
Supplemental Experimental Procedures.
IFNb Promoter Activity
To examine whether Vpu suppresses the expression of innate immunity genes,
293T cells were cotransfected with a firefly luciferase reporter construct under
the control of the IFNb promoter or a variant thereof with mutated NF-kB bind-
ing site, a Gaussia luciferase construct for normalization, and expression
vectors for vpu or an empty vector control. Cells were infected 16 hr posttrans-
fection with Sendai virus to activate the IFNb promoter. Luciferase activities
were determined 40 hr posttransfection.
Cytokine Array
Differences in cytokine release from cells infected with WT or vpu-deficient
CH167 were determined using a cytokine array as described in Supplemental
Experimental Procedures.
qRT-PCR
Gene expression levels were determined by qRT-PCR as outlined in Supple-
mental Experimental Procedures.
Flow Cytometry
Flow cytometric analyses were performed as outlined in Supplemental Exper-
imental Procedures.
Statistical Analysis
All statistical calculations were performed with a two-tailed unpaired Stu-
dent’s t test using Graph Pad Prism Version 5.03. p values < 0.05 were
considered significant. Correlations were calculated with the linear regres-
sion module.CSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.12.047.
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